VERSARTIS INC's ticker is VSAR and the CUSIP is 92529L102. A total of 56 filers reported holding VERSARTIS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $112,000 | -85.0% | 45,552 | +6.4% | 0.00% | -100.0% |
| Q2 2017 | $747,000 | -20.8% | 42,829 | -3.0% | 0.00% | -25.0% |
| Q1 2017 | $943,000 | +245.4% | 44,159 | +140.9% | 0.00% | +300.0% |
| Q4 2016 | $273,000 | -55.8% | 18,332 | -63.6% | 0.00% | -66.7% |
| Q3 2016 | $617,000 | -1.8% | 50,365 | -11.3% | 0.00% | 0.0% |
| Q2 2016 | $628,000 | +43.7% | 56,765 | +4.2% | 0.00% | +50.0% |
| Q1 2016 | $437,000 | +144.1% | 54,481 | +276.5% | 0.00% | +100.0% |
| Q4 2015 | $179,000 | +7.2% | 14,469 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $167,000 | -24.1% | 14,469 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $220,000 | +94.7% | 14,469 | +136.0% | 0.00% | – |
| Q1 2015 | $113,000 | -5.0% | 6,132 | +15.2% | 0.00% | -100.0% |
| Q4 2014 | $119,000 | +17.8% | 5,321 | 0.0% | 0.00% | – |
| Q3 2014 | $101,000 | -31.3% | 5,321 | +1.8% | 0.00% | -100.0% |
| Q2 2014 | $147,000 | – | 5,227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,296,471 | $51,556,000 | 25.09% |
| Aisling Capital LLC | 1,994,568 | $44,778,000 | 6.79% |
| Opaleye Management Inc. | 235,000 | $5,276,000 | 2.67% |
| Perceptive Advisors | 931,171 | $19,740,000 | 1.66% |
| HealthCor Management, L.P. | 875,000 | $19,644,000 | 1.10% |
| Cormorant Asset Management, LP | 200,000 | $4,490,000 | 0.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 644,150 | $14,461,000 | 0.63% |
| RA Capital Management | 231,267 | $5,192,000 | 0.56% |
| Baker Brothers Advisors | 2,281,744 | $51,225,000 | 0.52% |
| PFM Health Sciences, LP | 869,463 | $19,519,000 | 0.46% |